One in 10 US women miss cervical cancer screenings

November 5, 2014

Eight million US women have not been screened in the last five years for cervical cancer, even though regular checkups can help prevent the fatal disease, US health authorities said Wednesday.

About one in 10 , or 11.4 percent, aged 21 to 65 have gone years without screening, said the report by the US Centers for Disease Control and Prevention based on national registry data from 2007 to 2011.

"Every visit to a provider can be an opportunity to prevent by making sure women are referred for screening appropriately," said CDC principal deputy director Ileana Arias.

"We must increase our efforts to make sure that all women understand the importance of getting screened for cervical cancer. No woman should die from cervical cancer."

The agency recommends that most women receive a Pap smear at least once every three years and test for human papillomavirus every five years in women aged 30 to 65.

About half of new cases of cervical cancer each year arise among women who have not been properly screened, said the CDC.

About 12,000 women in the United States develop cervical cancer each year, and 4,000 die of the disease.

The Pap test was introduced in the 1950s and is credited with dramatically reducing the number of cervical cancer cases around the world.

"The Pap test is the most powerful tool ever developed that can save women's lives," said David Fishman, gynecological oncologist at The Mount Sinai Hospital in New York.

"The ability to detect precancerous change and intervene to prevent the development of a life threatening cancer using a simple, minimally invasive test is the holy grail of medicine."

Women in the southern United States had the highest rates of cervical cancer and death, and the largest percentage of unscreened patients in the country.

Women of Asian or Pacific Islander heritage were also the least likely to have been screened, with nearly 20 percent saying they had not been checked in five years.

Patients without health insurance were also more likely to have missed important screening exams.

Explore further: What's the best test for cervical cancer? Pap, HPV or both?

Related Stories

What's the best test for cervical cancer? Pap, HPV or both?

June 9, 2014
Should U.S. women be screened for cervical cancer with Pap tests, HPV tests or both? According to researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) while the merits of screening ...

Many women receive unnecessary Pap tests

October 1, 2014
As many as half to two-thirds of women who have undergone hysterectomies or are older than 65 years in the United States report receiving  Pap tests for cervical cancer. This prevalence is surprising in light of the 2003 ...

Screening helps prevent cervical cancer in older women

January 14, 2014
New research from Queen Mary University of London reveals women over the age of 50 who don't attend cervical screening are four times more likely to be diagnosed with cervical cancer in later life.

Millions given access to breast, cervical cancer screening: CDC

August 7, 2014
(HealthDay)—Millions of American women have benefited from a breast and cervical cancer screening program offered by the U.S. Centers for Disease Control and Prevention, according to a new report.

Cervical cancer symptoms not recognised by young women

September 29, 2014
(Medical Xpress)—New research led by King's College London suggests that many women under 30 with cervical cancer are diagnosed more than 3 months after first having symptoms. In many cases this was because they did not ...

Research makes connetion between tubal ligation and increase in cervical cancer rates

January 14, 2013
the surgical tying or severing of fallopian tubes to prohibit pregnancy – have less frequent Pap smears, which puts them at an increased risk for cervical cancer, according to research recently released by a team that included ...

Recommended for you

New findings explain how UV rays trigger skin cancer

October 18, 2017
Melanoma, a cancer of skin pigment cells called melanocytes, will strike an estimated 87,110 people in the U.S. in 2017, according to the Centers for Disease Control and Prevention. A fraction of those melanomas come from ...

Drug yields high response rates for lung cancer patients with harsh mutation

October 18, 2017
A targeted therapy resurrected by the Moon Shots Program at The University of Texas MD Anderson Cancer Center has produced unprecedented response rates among patients with metastatic non-small cell lung cancer that carries ...

Possible new immune therapy target in lung cancer

October 18, 2017
A study from Bern University Hospital in collaboration with the University of Bern shows that so-called perivascular-like cells from lung tumors behave abnormally. They not only inadequately support vascular structures, but ...

Many pelvic tumors in women may have common origin—fallopian tubes

October 17, 2017
Most—and possibly all—ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.

Researchers find novel mechanism of resistance to anti-cancer drugs

October 17, 2017
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However, many patients have tumors ...

New bowel cancer drug target discovered

October 17, 2017
Researchers at the Francis Crick Institute have discovered a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.